Immucell ICCC Cash Flow Statement (2010-2026)

NASDAQ ICCC
$10.22 +0.42 (+4.29%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Immucell Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Immucell reported cash from operations of $3.02M and free cash flow of $2.29M for the quarter ended Jun 2026, up 88.5% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
0.15M0.07M0.51M-0.68M-0.66M-1.67M-2.32M-1.38M-0.94M-1.14M-0.44M-1.53M-0.70M0.51M1.45M0.50M-0.14M-2.85M1.83M
Depreciation and DepletionDep. & Depletion
0.61M0.60M0.62M0.62M0.63M0.60M0.65M0.68M0.70M0.67M0.66M0.67M0.67M0.67M0.67M0.66M0.67M0.70M0.47M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Amortization of Deferred ChargesAmort. Deferred Charges
0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.03M0.00M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.62M0.60M0.62M0.63M0.63M0.61M0.66M0.69M0.71M0.68M0.68M0.68M0.69M0.68M0.69M0.68M0.71M0.71M0.47M
Share-based CompensationStock Comp.
0.05M0.04M0.05M0.06M0.09M0.07M0.10M0.08M0.10M0.10M0.08M0.10M0.08M0.07M0.05M0.07M0.07M0.10M0.24M
Deferred Taxes
Gains from Sales and DivestituresGains Divest
-0.04M0.00M0.01M0.00M-0.01M77.0068.00-834.000.00M0.01M-0.06M-0.05M0.00M
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
-719.00-718.000.00M0.01M0.00M0.02M0.01M0.02M0.07M-157.00-0.04M-0.04M-0.04M-0.04M-0.04M0.11M-0.38M0.02M-0.02M-0.02M
Change in Working Capital
Change in ReceivablesChange Receivables
0.37M0.27M-0.04M-1.24M0.29M0.06M0.33M-0.59M0.37M0.32M0.44M-0.67M0.36M1.46M-0.42M-0.97M0.18M0.86M-0.72M0.20M
Change in InventoryChange Inventory
0.25M0.42M0.35M1.17M0.71M0.72M0.29M1.21M-0.15M0.43M-0.66M0.15M0.16M-0.35M0.24M0.94M1.51M-0.53M-0.59M0.40M
Change in Account PayablesChange Payables
Change in Accrued ExpensesChange Accrued Exp.
0.15M0.37M-0.15M0.17M0.00M0.32M-0.26M0.25M-0.09M0.25M0.02M0.43M-0.06M-0.02M-0.53M0.23M0.13M-0.02M-0.15M0.62M
Change in Other Operating AssetsOther Assets Change
0.13M-0.20M0.10M-0.12M0.32M-0.13M0.34M-0.28M0.14M-0.13M0.11M-0.40M0.08M0.09M0.23M-0.14M0.11M-0.14M0.23M-0.44M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
-0.13M0.20M-0.10M0.12M-0.32M0.13M-0.34M0.28M-0.14M0.13M-0.11M0.40M-0.08M-0.09M-0.23M0.14M-0.11M0.14M-0.23M0.44M
Cash from OperationsCash from Ops.
0.26M0.59M0.64M0.37M-1.26M-1.30M-2.76M-0.68M-0.51M-0.72M0.42M0.58M-0.64M0.00M1.57M1.60M-1.18M0.48M3.57M3.02M
Investing Activities
Capital ExpendituresCapex
0.68M0.70M0.81M0.94M0.73M1.49M0.68M0.71M0.54M-0.03M0.07M0.11M0.09M0.20M0.33M0.16M0.59M0.17M0.18M0.73M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M0.00M0.01M15.0076.000.00M0.00M0.01M0.01M
Change in Property, Plant and EquipmentChange in PP&E
-0.67M-0.70M-0.80M-0.94M-0.73M-1.49M-0.68M-0.71M-0.53M0.03M-0.07M-0.11M-0.09M-0.20M-0.33M-0.16M-0.59M-0.17M-0.17M-0.73M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
-0.67M-0.70M-0.80M-0.94M-0.73M-1.49M-0.68M-0.71M-0.53M0.03M-0.07M-0.11M-0.09M-0.20M-0.33M-0.13M-0.59M-0.17M-0.17M-0.73M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
2.00M2.33M
Long-Term Debt RepaymentsLT Debt Repayment
0.19M0.19M0.20M0.23M0.22M0.25M0.25M0.25M0.33M0.36M0.36M0.36M0.37M0.37M0.38M0.38M1.12M0.39M0.40M0.40M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.19M-0.19M1.80M-0.23M-0.22M-0.25M-0.25M-0.25M-0.33M-0.36M-0.36M-0.36M-0.37M-0.37M-0.38M-0.38M1.20M-0.39M-0.40M-0.40M
Short-Term Debt issuancesST Debt Issuance
1.00M1.00M
Short-Term Debt repaymentsST Debt Repayment
Net Short-Term Debt Issued (Repaid)Net ST Debt
1.00M1.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.19M-0.19M1.80M-0.23M-0.22M-0.25M0.75M-0.25M0.67M-0.36M-0.36M-0.36M-0.37M-0.37M-0.38M-0.38M1.20M-0.39M-0.40M-0.40M
Change in Capital Stock
Common Stock IssuedStock Issued
0.17M0.01M0.02M-2.001.00M3.69M0.54M0.02M0.33M4.000.16M
Net Shares Issued and RepurchasedNet Shares Issued
0.17M0.01M0.02M-2.001.00M3.69M0.54M0.02M0.33M4.000.16M
Net Equity Issued and RepurchasedNet Equity Issued
0.17M0.01M0.02M-2.001.00M3.69M0.54M0.02M0.33M4.000.16M
Other financing activities (as filed)
0.08M-0.02M0.02M-0.01M-0.16M-0.11M-0.02M-0.04M-0.02M-0.01M
Cash from Financing ActivitiesCash from Financing
0.21M-0.19M1.79M-0.20M-0.22M-0.25M0.75M-0.25M1.58M-0.32M-0.37M-0.11M3.21M0.15M-0.40M-0.08M-0.34M-0.39M-0.40M-0.24M
Additional items
Change in Cash
-0.20M-0.31M1.63M-0.77M-2.22M-3.04M-2.70M-1.64M0.54M-1.01M-0.02M0.36M2.48M-0.05M0.84M1.40M-2.11M-0.08M3.01M2.05M
Ending Cash Balance
10.50M10.19M11.82M11.04M8.83M5.79M3.10M1.45M1.99M0.98M0.96M1.32M3.81M3.76M6.00M3.89M3.81M8.86M
Free Cash FlowFCF
-0.42M-0.12M-0.17M-0.57M-1.99M-2.79M-3.44M-1.39M-1.04M-0.69M0.35M0.47M-0.73M-0.20M1.24M1.45M-1.78M0.31M3.40M2.29M
Net Cash FlowNCF
-0.20M-0.31M1.63M-0.77M-2.22M-3.04M-2.70M-1.64M0.54M-1.01M-0.02M0.36M2.48M-0.05M0.84M1.40M-2.11M-0.08M3.01M2.05M
Interest Paid
0.08M0.07M0.07M0.09M0.09M0.09M0.09M0.09M0.13M0.14M0.14M0.13M0.13M0.12M0.12M0.12M0.11M0.10M0.10M0.09M
Income Taxes PaidTaxes Paid
10.00-25.000.07M0.09M-0.15M348.000.01M-739.000.00M0.01M0.01M

Immucell Cash Flow Statement API

Pull Immucell's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ICCC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY